glp-1 in heart failure The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Impact of GLP-1 receptor agonists

In addition to the review's focus, other topics that cover anti-obesity and anti-diabetic drugs with the potential against PCa proliferation also need further investigation

Kreiner FF, Hovingh GKK, Von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure

The spider's venom protein has been found to protect the striatal region of the brain

Its why patients across the Tri-Cities drive past other options to see him, and why so many of those patients become long-term clients across multiple services

Sulfonylureas: a new look at old therapy

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Ryden L, et al